Analysis of Global Research Trends in Immunoconjugates for Cervical Cancer: A Bibliometric and Thematic Mapping Study from 2015 to 2024 - Top-Institutions - MDSpire

Analysis of Global Research Trends in Immunoconjugates for Cervical Cancer: A Bibliometric and Thematic Mapping Study from 2015 to 2024

  • By

  • Xiaodong Wang

  • Di Xiong

  • Songli Cui

  • Bingchen Duan

  • Gouping Ding

  • Yiping Huang

  • Qianqian Wang

  • April 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Gynecologic Oncology
    • Immunotherapy
    • Translational Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Gynecologic Oncology
    • Immunotherapy
    • Cancer Drug Development

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Gynecologic Oncology
    • Immunotherapy
    • Cancer Biology

  • #4

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Clinical Trials
    • Immunotherapy

  • #5

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Gynecologic Oncology
    • Immunotherapy
    • Translational Medicine

Original Source(s)

Analysis of Global Research Trends in Immunoconjugates for Cervical Cancer: A Bibliometric and Thematic Mapping Study from 2015 to 2024

  • by Xiaodong Wang, Di Xiong, Songli Cui, Bingchen Duan, Gouping Ding, Yiping Huang, Qianqian Wang

  • April 23, 2026

Related Content

Financial Hardship and Nonadherence to Lifestyle and Surveillance in Childhood Cancer Survivors

FOXA2 in cancer: from fundamental biology to clinical translation

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study